scispace - formally typeset
P

Philippe Marianneau

Researcher at Pasteur Institute

Publications -  49
Citations -  2485

Philippe Marianneau is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Virus & Dengue virus. The author has an hindex of 24, co-authored 44 publications receiving 2283 citations. Previous affiliations of Philippe Marianneau include French Institute of Health and Medical Research & ANSES.

Papers
More filters
Journal ArticleDOI

Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children

TL;DR: It is suggested that the hepatocyte and Kupffer cells may be target cells supporting virus replication and that the councilman body is an apoptotic cell, as in the pathogenesis of yellow fever.
Journal ArticleDOI

Report of a fatal case of dengue infection with hepatitis: Demonstration of dengue antigens in hepatocytes and liver apoptosis

TL;DR: Findings suggest that hepatocytes are the major sites of DEN virus replication in the liver and that DEN virus induces apoptosis of hepatocytes in vivo.
Journal ArticleDOI

Nipah Virus: Vaccination and Passive Protection Studies in a Hamster Model

TL;DR: It is shown that both of the Nipah virus glycoproteins (G and F) when expressed as vaccinia virus recombinants induced an immune response in hamsters which protected against a lethal challenge by Nipahs virus.
Journal ArticleDOI

Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death.

TL;DR: It is shown here that infection of the hepatoma cell line HepG2 with DEN type 1 virus induced cell death typical of apoptosis late in the virus cycle, and this may be a key element in the pathophysiology of hepatic failure associated with DHF-DSS.
Journal ArticleDOI

A golden hamster model for human acute Nipah virus infection

TL;DR: A golden hamster (Mesocricetus auratus) model is proposed as a suitable model for further studies including pathogenesis studies, anti-viral drug testing, and vaccine development against acute Nipah infection.